Were Analysts Bullish Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) This Week?

April 16, 2018 - By Paul Bridgeforth

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) LogoInvestors sentiment increased to 3.89 in 2017 Q4. Its up 2.53, from 1.36 in 2017Q3. It increased, as 5 investors sold Idera Pharmaceuticals, Inc. shares while 13 reduced holdings. 35 funds opened positions while 35 raised stakes. 142.24 million shares or 202.82% more from 46.97 million shares in 2017Q3 were reported.
Leavell Investment has invested 0.02% in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). California Employees Retirement stated it has 0% in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). Citigroup accumulated 0% or 14,630 shares. State Board Of Administration Of Florida Retirement Sys has 0% invested in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) for 19,240 shares. State Common Retirement Fund accumulated 96,300 shares. Bnp Paribas Arbitrage invested in 29,251 shares. 48,919 were reported by Premier Asset Limited Liability Corporation. Deutsche Bancorporation Ag holds 0% or 310,011 shares. Cambridge Inv Rech Advsr invested in 0% or 18,000 shares. Balyasny Asset Mngmt Limited Co holds 0% or 59,416 shares. 22,587 are held by Metropolitan Life Insur. Morgan Stanley reported 356,570 shares stake. Broadfin Limited Liability Com has invested 0.7% of its portfolio in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). Two Sigma Ltd Liability Company reported 16,220 shares. Parallax Volatility Advisers Limited Partnership reported 21,588 shares or 0% of all its holdings.

Since October 26, 2017, it had 1 insider purchase, and 2 sales for $7.00 million activity. The insider BAKER BROS. ADVISORS LP bought $12.00 million.

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Ratings Coverage

Among 2 analysts covering Idera Pharmaceuticals (NASDAQ:IDRA), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Idera Pharmaceuticals had 4 analyst reports since November 9, 2017 according to SRatingsIntel. H.C. Wainwright maintained it with “Buy” rating and $4.0 target in Friday, March 9 report. The firm has “Buy” rating by H.C. Wainwright given on Thursday, November 16. On Thursday, November 9 the stock rating was maintained by Piper Jaffray with “Buy”. Below is a list of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) latest ratings and price target changes.

09/03/2018 Broker: H.C. Wainwright Rating: Buy New Target: $4.0 Maintain
16/11/2017 Broker: H.C. Wainwright Rating: Buy New Target: $4.0 Maintain
09/11/2017 Broker: Piper Jaffray Rating: Buy New Target: $4.0 Maintain
09/11/2017 Broker: H.C. Wainwright Rating: Buy New Target: $4 Initiates Coverage On

The stock decreased 0.18% or $0.0034 during the last trading session, reaching $1.8666. About 153,879 shares traded. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has declined 21.96% since April 16, 2017 and is downtrending. It has underperformed by 33.51% the S&P500.

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of oligonucleotide therapeutics for oncology and rare diseases in the United States. The company has market cap of $403.20 million. It uses two drug discovery technology platforms to design and develop drug candidates, including toll-like receptor targeting technology and third-generation antisense technology. It currently has negative earnings. The companyÂ’s drug candidates include IMO-2125, an agonist that is in Phase I/II clinical trials in combination with ipilimumab and pembrolizumab for the treatment of anti-PD-1 refractory metastatic melanoma and refractory solid tumors; IMO-8400, an antagonist, which is in Phase II clinical trial for the treatment of dermatomyositis.

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Science

Paris Climate goals could save us money

Paris Climate goals could save us money

Marguerite Chambers

The goal of 1.5°C from Paris Climate agreements would save dozens of trillions of dollars. At least, according to the researchers, it could save a planet. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with ...

Hot weather can raise antibiotic resistance

Hot weather can raise antibiotic resistance

Louis Casey

The new level of resistance to antibiotics is higher than expected and can be explained by climate change and growing numbers of the population. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE ...

Bioengineered angiogenic gel grows new brain tissue

Bioengineered angiogenic gel grows new brain tissue

Linda Rogers

Scientists from the Los Angeles University of California have created a special angiogenic gel that increases the growth of brain tissue and forms axonal networks in the blood vessels that were regenerated. That’s what happened when researchers injected the new medicine in mice’s stroke cavity. Receive News & Ratings Via Email - ...

Chinese satellite Queqiao launched to the moon

Chinese satellite Queqiao launched to the moon

Kelly Oliver

China has recently successfully launched its lunar satellite Queqiao. According to the official plans, the satellite will help with communication between lunar lander and Earth, as well as performing radio astronomy. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest ...

Rocket Antares brings new supplies on International Space Station

Rocket Antares brings new supplies on International Space Station

Edwin Martin

It looks like this launch of Antares rocket was expected more than the flight of first human mission on Mars. And the reason is in cargo itself. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings ...

Sally Ride on a postage stamp

Sally Ride on a postage stamp

Ellis Scott

An astronaut has signed her own photo 35 years ago. She did not know that someday it would be turned into postage stamp of the USA. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with ...

Physics and science fiction met together at Fermilab

Physics and science fiction met together at Fermilab

Dolores Ford

According to the physicist from Fermilab, Cindy Joe stories are an important part of daily work of a scientist. That’s when Story Collider decided to gather storytellers from different sides of science into live shows and podcasts. Receive News & Ratings Via Email - Enter your email address below to receive a ...

Do we need to change our space goals on Venus

Do we need to change our space goals on Venus

Darrin Black

NASA and Donald Trump, the USA president, have big plans on Mars’ exploration and upcoming mission on the red planet. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Why Mars changes its colors

Why Mars changes its colors

Vivian Park

If you are interested in astronomy, you may have noticed that Mars is definitely brighter this year, than it was before 2003 for example. Is it true? Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings ...

Big Bang model will be created on ISS

Big Bang model will be created on ISS

Thomas Roop

Antares rocket with all 7, 400 pounds of supplies on board was successfully launched from Virginia yesterday. It contained Cold Atom Laboratory which is able to freeze atoms to absolute zero temperatures, colder than space vacuum and create Bose-Einstein condensates. Receive News & Ratings Via Email - Enter your email address below ...